RT Journal Article
SR Electronic
T1 Distributions and risks of SARS-CoV-2 in hospital outdoor environment
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.12.20097105
DO 10.1101/2020.05.12.20097105
A1 Dayi Zhang
A1 Yunfeng Yang
A1 Xia Huang
A1 Jingkun Jiang
A1 Miao Li
A1 Xian Zhang
A1 Haibo Ling
A1 Jing Li
A1 Yi Liu
A1 Guanghe Li
A1 Weiwei Li
A1 Chuan Yi
A1 Ting Zhang
A1 Yongzhong Jiang
A1 Songqiang Deng
A1 Peng Zhao
A1 Jiuhui Qu
YR 2020
UL http://medrxiv.org/content/early/2020/05/18/2020.05.12.20097105.abstract
AB The outbreak of coronavirus infectious disease-2019 (COVID-19) pneumonia since 2019 has rapidly spread throughout over 200 countries around the world. Till 14th May 2020, there are over 4 million confirmed cases and 300,000 deaths globally 1. To date, numerous studies focus on the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in indoor areas for its main transmission routes via human respiratory droplets and direct contact 2,3. It remains unclear about the distribution and transmission risks of SARS-CoV-2 in outdoor environment despite its threats to healthy people and communities. Here, we investigated the presence of SARS-CoV-2 virus in 73 specimens from outdoor environment of three hospitals in Wuhan. We found SARS-CoV-2 in soils (205-550 copies/g), wastewaters (255 to 1.9×104 copies/L) and aerosols (285-1130 copies/m3) in locations close to departments receiving COVID-19 patients or in wastewater treatment sectors, which revealed significant viral spill-over in hospital outdoor environment that was possibly via respiratory droplets from patients or airborne aerosols from wastewater containing SARS-CoV-2. In contrast, SARS-CoV-2 was not detected in other areas or on surfaces with regular disinfection. Soils eventually behave as viral receptors through deposition and potentially a secondary source spreading SARS-CoV-2 for a prolonged time. Our findings map the high-risk areas in hospital outdoor environment possessing spread risks of SARS-CoV-2, which require particular attention and complete sanitation for preventing SARS-CoV-2 outdoor transmission.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNAAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the authors by request.